The impact of smoking on third-degree atrioventricular block outcomes: A propensity-matched analysis

Mirza Faris Ali Baig1, Kalyan Chaliki2

  • 1Asante Three Rivers Medical Center, 500 SW Ramsey Avenue, Grants Pass, OR, USA, 97527.

Insights

Patients with third-degree atrioventricular (AV) block and a history of smoking experienced lower in-hospital mortality and costs. This study analyzed 5,560 matched patients, finding smokers had better outcomes, including reduced cardiogenic shock and shorter hospital stays.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Third-degree atrioventricular (AV) block is a rare but serious condition requiring immediate intervention, often attributed to coronary artery disease (CAD).
  • Smoking is a major risk factor for CAD, yet its direct impact on third-degree AV block outcomes is not well-documented.

Purpose of the Study:

  • To investigate the association between smoking history and clinical outcomes in patients diagnosed with third-degree AV block.
  • To analyze in-hospital mortality, complication rates, and healthcare resource utilization in relation to smoking status.

Main Methods:

  • A retrospective cohort study utilized the National Inpatient Sample (NIS) database from 2019-2020.
  • Included adult admissions with a primary diagnosis of third-degree AV block and a history of smoking.
  • Analyzed outcomes including mortality, cardiogenic shock, cardiac arrest, length of stay (LOS), and hospitalization costs, using multivariable regression and propensity score matching.

Main Results:

  • The study included 77,650 admissions, with 29,380 (37.8%) patients identified as smokers.
  • After propensity score matching (5,560 patients), smokers showed significantly decreased odds of in-hospital mortality (aOR, 0.59; CI, 0.44-0.78).
  • Smokers also experienced reduced rates of cardiogenic shock, cardiac arrest, tracheal intubation, mechanical ventilation, shorter LOS, and lower total hospitalization costs.

Conclusions:

  • Third-degree AV block patients with a smoking history demonstrated better in-hospital outcomes compared to non-smokers.
  • These outcomes include lower mortality, fewer severe complications like cardiogenic shock and cardiac arrest, and reduced healthcare resource utilization.
Abstract

Related Concept Videos

Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
432
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
353
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
969